Fungal toxins and multiple sclerosis: A compelling connection

Brain Research Bulletin

Volumn 82, Issue 1-2, 2010, Pages 4-6

  Purzycki, Catherine B ^a   Shain, Daniel H ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Astrocytes; Blood brain barrier; Multiple sclerosis; Neurodegeneration; Oligodendrocytes; Toxins

Indexed keywords

AFLATOXIN; FUMONISIN B1; GLIOTOXIN; IMMUNOGLOBULIN KAPPA CHAIN; MANNAN; MANNOPROTEIN; MYCOTOXIN; MYELIN;

ALLERGIC ENCEPHALOMYELITIS; APOPTOSIS; ASPERGILLUS; ASTROCYTE; CANDIDA ALBICANS; DEMYELINATING DISEASE; DISEASE ASSOCIATION; FUNGAL VIRULENCE; FUSARIUM; GLIA CELL; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

ANIMALS; FUNGI; HUMANS; MULTIPLE SCLEROSIS; MYCOTOXINS; NEUROGLIA;

EID: 77952322410     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.02.012     Document Type: Review

References (33)

1. Alvarez-Lafuente R., delas Heras V., Garcia-Montojo M., Bartolome M., Arroyo R. Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive. Mult. Scler. 2007, 13:578-583.
2. Aulchenko Y., Hoppenbrouwers I., Ramagopalan S., Broer L., Jafari N., Hillert J., Link J., Lundstrom W., Greiner E., Sadovnick A., Goossens D., Van Broeckhoven C.J., Delfavero J., Ebers G., Oostra B., Vanduijn C., Hintzen R. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat. Gen. 2008, 20:1402-1403.
3. Baranzini S.E., Wang J., Gibson R., Galwey N., Naegelin Y., Barkhof F., Radue E., Lindberg R., Uitdehaag B., Johnson M., Angelakopoulou A., Hall L., Richardson J., Prinjha R., Gass A., Geurts J., Kragt J., Sombekke M., Vrenken H., Qualley P., Lincoln R., Gomez R., Caillier S., George M., Mousavi H., Guerrero R., Okuda D., Cree B., Green A., Waubant E., Goodin D., Pelletier D., Matthews P., Hauser S., Kappos L., Polman C., Oksenberg J. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum. Mol. Gen. 2009, 18:767-778.
4. Benjelloun N., Charriaut-Marlangue C., Hantaz-Ambroise D., Ménard A., Pierig R., Alliel P.M., Rieger F. Induction of cell death in rat brain by a gliotoxic factor from cerebrospinal fluid in multiple sclerosis. Cell. Mol. Biol. 2002, 48:205-212.
5. Bernardo P., Brasch N., Chai C., Waring P. A novel redox mechanism for the glutathione-dependent reversible uptake of a fungal toxin in cells. J. Biol. Chem. 2003, 278:46549-46555.
6. Caillier S., Briggs F., Cree B., Baranzini S., Fernandez-Vina M., Ramsay P., Khan O., Royal W., Hauser S., Barcelos L., Oksenberg J., et al. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J. Immun. 2008, 181:5473-5480.
7. Cavanagh J.B., Holton J.L., Nola C.C., Ray D.E., Naik J.T., Mantle P.G. The effects of the tremorgenic mycotoxin penitrem A on the rat cerebellum. Vet. Pathol. 1998, 35:53-63.
8. Charcot J. Gaz. Hôp. 1868, 41:554-555.
9. 2+ exchanger. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8168-8173.
10. Davison A.N., Sabri M.I. Biosynthesis of myelin and neurotoxic factors in the serum of multiple sclerosis patients. Adv. Exp. Med. Biol. 1978, 100:19-25.
11. Etzel R., Mycotoxins JAMA 2002, 287:425-427.
12. Hartung H.P., Rieckmann P. Pathogenesis of immune-mediated demyelination in the CNS. J. Neural Transm. Suppl. 1997, 50:173-181.
13. Jenkins M.A., Cheng L., Ratnaike S. Multiple sclerosis: use of light-chain typing to assist diagnosis. Ann. Clin. Biochem. 2001, 38:235-241.
14. Kondori N., Edebo L., Mattsby-Baltzer I. Circulating β (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis. Clin. Diag. Lab. Immun. 2004, 11:344-350.
15. Kosalec I., Pepeljnjak S. Chemistry and biological effects of gliotoxin. Arh. Hig. Rada Toksikol. 2004, 55:313-320.
16. Lunemann J.D., Kamradt T., Martin R., Munz C. Epstein-barr virus: environmental trigger of multiple sclerosis?. J. Virol. 2007, 81:6777-6784.
17. Malcus-Vocanson C., Giraud P., Broussole E., Perron H., Mandrand B., Chazot G. A urinary marker for multiple sclerosis. Lancet 1998, 351:1330.
18. Mao P., Reddy P. Is multiple sclerosis a mitochondrial disease?. Biochim. Biophys. Acta 2009, 10.1016/j.bbadis.2009.07.002.
19. Menard A., Amouria R., Toma D., Charriaut-Marlangueb C., Pierig R., Cifuentes-Diaz C., Ghandour S., Belliveau J., Gascan H., Hentati F., Lyon-Caenf O., Perron H., Rieger F. A gliotoxic factor and multiple sclerosis. J. Neurol. Sci. 1998, 154:209-221.
20. Pender M.P. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection. Autoim. Rev. 2009, 8:563-568.
21. Pierig R., Belliveau J., Amouri R., Menard A., Reiger F. Association of a gliotoxic activity with active multiple sclerosis in US patients. Cell. Mol. Biol. 2002, 48:199-203.
22. Ramagopalan S.V., Maugeri N., Handunnetthi L., Lincoln M., Orton S., Dyment D., Deluca G., Herrera B., Chao M., Sadovnick A., Ebers G., Knight J. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB11501 is regulated by vitamin D. PLoS Gen. 2009, 2:e1000369.
23. Rieger F., Amouri R., Benjelloun N., Cifuentes-Diaz C., Lyon-Caen O., Hantaz-Ambroise D., Dobransky T., Perron H., Gemy C. Gliotoxic factor and multiple sclerosis. C. R. Acad. Sci. III 1996, 319:343-350.
24. Sadovnik A.D. Familiar recurrence risks and inheritance of multiple sclerosis. Curr. Opin. Neurol. Neurosurg. 1993, 2:189-196.
25. Smith K.J. Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy. Brain Path. 2007, 17:230-242.
26. Stockmann-Juvala H., Savolainen K. A review of the toxic effects and mechanisms of action of fumonisin B1. Hum. Exp. Toxicol. 2008, 27:799-809.
27. Stys P.K. General mechanisms of axonal damage and its prevention. J. Neurol. Sci. 2005, 233:3-13.
28. Tubuc C., Marin D., Guerre P., Sesan T., Bailly J.D. Molds and mycotoxin content of cereals in southeastern Romania. Food Prot. 2009, 72:662.
29. Wheeler R.T., Fink G.R. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog. 2006, 2:e35.
30. Wheeler D., Bandaru V.V., Calabresi P.A., Nath A., Haughy N.J. A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain 2008, 131:3092-3102.
31. Wheeler R.T., Kombe D., Agarwala S.D., Fink G.R. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog. 2008, 4:e1000227.
32. Willis C.L., Leach L., Clarke G.C., Nolan C.J., Ray D.E. Reversible disruption of tight junction complexes in the rat blood-brain barrier, following transitory focal astrocyte loss. Glia 2004, 48:1-13.
33. Yu J., Bhatnagar D., Ehrlich K.C. Aflatoxin biosynthesis. Rev. Iberoam. Micol. 2002, 19:191-200.